HEADER TRANSFERASE/TRANSFERASE INHIBITOR 17-JUN-16 5KJ2 TITLE THE NOVEL P300/CBP INHIBITOR A-485 UNCOVERS A UNIQUE MECHANISM OF TITLE 2 ACTION TO TARGET AR IN CASTRATE RESISTANT PROSTATE CANCER COMPND MOL_ID: 1; COMPND 2 MOLECULE: HISTONE ACETYLTRANSFERASE P300; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: P300 HAT,E1A-ASSOCIATED PROTEIN P300; COMPND 5 EC: 2.3.1.48; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: EP300, P300; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS HISTONE ACETYLTRANSFERASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR C.G.JAKOB,W.QIU,R.P.EDALJI,C.SUN REVDAT 4 27-SEP-23 5KJ2 1 REMARK REVDAT 3 10-APR-19 5KJ2 1 JRNL REVDAT 2 01-NOV-17 5KJ2 1 COMPND HETNAM HETSYN FORMUL REVDAT 1 27-SEP-17 5KJ2 0 JRNL AUTH L.M.LASKO,C.G.JAKOB,R.P.EDALJI,W.QIU,D.MONTGOMERY, JRNL AUTH 2 E.L.DIGIAMMARINO,T.M.HANSEN,R.M.RISI,R.FREY,V.MANAVES, JRNL AUTH 3 B.SHAW,M.ALGIRE,P.HESSLER,L.T.LAM,T.UZIEL,E.FAIVRE, JRNL AUTH 4 D.FERGUSON,F.G.BUCHANAN,R.L.MARTIN,M.TORRENT,G.G.CHIANG, JRNL AUTH 5 K.KARUKURICHI,J.W.LANGSTON,B.T.WEINERT,C.CHOUDHARY, JRNL AUTH 6 P.DE VRIES,J.H.VAN DRIE,D.MCELLIGOTT,E.KESICKI, JRNL AUTH 7 R.MARMORSTEIN,C.SUN,P.A.COLE,S.H.ROSENBERG,M.R.MICHAELIDES, JRNL AUTH 8 A.LAI,K.D.BROMBERG JRNL TITL DISCOVERY OF A SELECTIVE CATALYTIC P300/CBP INHIBITOR THAT JRNL TITL 2 TARGETS LINEAGE-SPECIFIC TUMOURS. JRNL REF NATURE V. 550 128 2017 JRNL REFN ESSN 1476-4687 JRNL PMID 28953875 JRNL DOI 10.1038/NATURE24028 REMARK 2 REMARK 2 RESOLUTION. 1.95 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.7 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.95 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 24.39 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 29145 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.227 REMARK 3 R VALUE (WORKING SET) : 0.225 REMARK 3 FREE R VALUE : 0.260 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.850 REMARK 3 FREE R VALUE TEST SET COUNT : 1414 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.000 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 15 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.95 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.02 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.93 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2809 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2630 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2677 REMARK 3 BIN R VALUE (WORKING SET) : 0.2600 REMARK 3 BIN FREE R VALUE : 0.3140 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.70 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 132 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.000 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2586 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 39 REMARK 3 SOLVENT ATOMS : 259 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 34.95 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 39.78 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 3.49960 REMARK 3 B22 (A**2) : -0.38520 REMARK 3 B33 (A**2) : -3.11440 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.310 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.188 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.164 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.177 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.159 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.936 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.917 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2699 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 3665 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 915 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 62 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 399 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2699 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : 3 ; 5.000 ; SEMIHARMONIC REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 338 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 3236 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.11 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.30 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 18.00 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5KJ2 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 20-JUN-16. REMARK 100 THE DEPOSITION ID IS D_1000221980. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 08-OCT-14 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 29345 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.950 REMARK 200 RESOLUTION RANGE LOW (A) : 168.440 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 6.600 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 20.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.95 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.95 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 6.90 REMARK 200 R MERGE FOR SHELL (I) : 0.87000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 3BIY REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 52.92 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.61 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 25% (W/V) PEG3350, 0.2M SODIUM REMARK 280 CHLORIDE, 0.1M BIS-TRIS BUFFER PH5.5, VAPOR DIFFUSION, REMARK 280 TEMPERATURE 290K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 84.21900 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 84.21900 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 22.59600 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 51.47200 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 22.59600 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 51.47200 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 84.21900 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 22.59600 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 51.47200 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 84.21900 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 22.59600 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 51.47200 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 150 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 15370 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -9.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASN A 1559 REMARK 465 LYS A 1560 REMARK 465 SER A 1561 REMARK 465 SER A 1562 REMARK 465 LEU A 1563 REMARK 465 SER A 1564 REMARK 465 ARG A 1565 REMARK 465 GLY A 1566 REMARK 465 ASN A 1567 REMARK 465 LYS A 1568 REMARK 465 LYS A 1569 REMARK 465 LYS A 1570 REMARK 465 PRO A 1571 REMARK 465 GLY A 1572 REMARK 465 MET A 1573 REMARK 465 PRO A 1574 REMARK 465 ASN A 1575 REMARK 465 VAL A 1576 REMARK 465 SER A 1577 REMARK 465 ASN A 1578 REMARK 465 SER A 1662 REMARK 465 GLN A 1663 REMARK 465 ASP A 1664 REMARK 465 ARG A 1665 REMARK 465 PHE A 1666 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A1292 CG CD NE CZ NH1 NH2 REMARK 470 ARG A1311 CG CD NE CZ NH1 NH2 REMARK 470 ARG A1342 CG CD NE CZ NH1 NH2 REMARK 470 ILE A1366 CG1 CG2 CD1 REMARK 470 LEU A1371 CG CD1 CD2 REMARK 470 GLU A1442 CG CD OE1 OE2 REMARK 470 LYS A1456 CG CD CE NZ REMARK 470 LYS A1523 CG CD CE NZ REMARK 470 ARG A1635 CG CD NE CZ NH1 NH2 REMARK 470 LEU A1644 CG CD1 CD2 REMARK 470 ARG A1645 CG CD NE CZ NH1 NH2 REMARK 470 VAL A1656 CG1 CG2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A1288 64.73 -106.42 REMARK 500 HIS A1402 25.87 -64.73 REMARK 500 SER A1441 -168.86 -74.19 REMARK 500 GLU A1442 96.45 -57.47 REMARK 500 TYR A1446 -79.13 -84.81 REMARK 500 CYS A1450 98.82 54.72 REMARK 500 CYS A1621 97.10 -163.91 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A2056 DISTANCE = 5.86 ANGSTROMS REMARK 525 HOH A2057 DISTANCE = 6.62 ANGSTROMS REMARK 525 HOH A2058 DISTANCE = 7.85 ANGSTROMS REMARK 525 HOH A2059 DISTANCE = 8.66 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 6TF A 1701 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue NA A 1702 DBREF 5KJ2 A 1287 1666 UNP Q09472 EP300_HUMAN 1287 1666 SEQADV 5KJ2 A UNP Q09472 GLU 1523 DELETION SEQADV 5KJ2 A UNP Q09472 GLU 1524 DELETION SEQADV 5KJ2 A UNP Q09472 GLU 1525 DELETION SEQADV 5KJ2 A UNP Q09472 GLU 1526 DELETION SEQADV 5KJ2 A UNP Q09472 ARG 1527 DELETION SEQADV 5KJ2 A UNP Q09472 LYS 1528 DELETION SEQADV 5KJ2 A UNP Q09472 ARG 1529 DELETION SEQADV 5KJ2 A UNP Q09472 GLU 1530 DELETION SEQADV 5KJ2 A UNP Q09472 GLU 1531 DELETION SEQADV 5KJ2 A UNP Q09472 ASN 1532 DELETION SEQADV 5KJ2 A UNP Q09472 THR 1533 DELETION SEQADV 5KJ2 A UNP Q09472 SER 1534 DELETION SEQADV 5KJ2 A UNP Q09472 ASN 1535 DELETION SEQADV 5KJ2 A UNP Q09472 GLU 1536 DELETION SEQADV 5KJ2 A UNP Q09472 SER 1537 DELETION SEQADV 5KJ2 A UNP Q09472 THR 1538 DELETION SEQADV 5KJ2 A UNP Q09472 ASP 1539 DELETION SEQADV 5KJ2 A UNP Q09472 VAL 1540 DELETION SEQADV 5KJ2 A UNP Q09472 THR 1541 DELETION SEQADV 5KJ2 A UNP Q09472 LYS 1542 DELETION SEQADV 5KJ2 A UNP Q09472 GLY 1543 DELETION SEQADV 5KJ2 A UNP Q09472 ASP 1544 DELETION SEQADV 5KJ2 A UNP Q09472 SER 1545 DELETION SEQADV 5KJ2 A UNP Q09472 LYS 1546 DELETION SEQADV 5KJ2 A UNP Q09472 ASN 1547 DELETION SEQADV 5KJ2 A UNP Q09472 ALA 1548 DELETION SEQADV 5KJ2 A UNP Q09472 LYS 1549 DELETION SEQADV 5KJ2 A UNP Q09472 LYS 1550 DELETION SEQADV 5KJ2 A UNP Q09472 LYS 1551 DELETION SEQADV 5KJ2 A UNP Q09472 ASN 1552 DELETION SEQADV 5KJ2 A UNP Q09472 ASN 1553 DELETION SEQADV 5KJ2 A UNP Q09472 LYS 1554 DELETION SEQADV 5KJ2 ARG A 1637 UNP Q09472 LYS 1637 ENGINEERED MUTATION SEQADV 5KJ2 GLY A 1652 UNP Q09472 MET 1652 ENGINEERED MUTATION SEQRES 1 A 348 LYS PHE SER ALA LYS ARG LEU PRO SER THR ARG LEU GLY SEQRES 2 A 348 THR PHE LEU GLU ASN ARG VAL ASN ASP PHE LEU ARG ARG SEQRES 3 A 348 GLN ASN HIS PRO GLU SER GLY GLU VAL THR VAL ARG VAL SEQRES 4 A 348 VAL HIS ALA SER ASP LYS THR VAL GLU VAL LYS PRO GLY SEQRES 5 A 348 MET LYS ALA ARG PHE VAL ASP SER GLY GLU MET ALA GLU SEQRES 6 A 348 SER PHE PRO TYR ARG THR LYS ALA LEU PHE ALA PHE GLU SEQRES 7 A 348 GLU ILE ASP GLY VAL ASP LEU CYS PHE PHE GLY MET HIS SEQRES 8 A 348 VAL GLN GLU TYR GLY SER ASP CYS PRO PRO PRO ASN GLN SEQRES 9 A 348 ARG ARG VAL TYR ILE SER TYR LEU ASP SER VAL HIS PHE SEQRES 10 A 348 PHE ARG PRO LYS CYS LEU ARG THR ALA VAL TYR HIS GLU SEQRES 11 A 348 ILE LEU ILE GLY TYR LEU GLU TYR VAL LYS LYS LEU GLY SEQRES 12 A 348 TYR THR THR GLY HIS ILE TRP ALA CYS PRO PRO SER GLU SEQRES 13 A 348 GLY ASP ASP TYR ILE PHE HIS CYS HIS PRO PRO ASP GLN SEQRES 14 A 348 LYS ILE PRO LYS PRO LYS ARG LEU GLN GLU TRP TYR LYS SEQRES 15 A 348 LYS MET LEU ASP LYS ALA VAL SER GLU ARG ILE VAL HIS SEQRES 16 A 348 ASP TYR LYS ASP ILE PHE LYS GLN ALA THR GLU ASP ARG SEQRES 17 A 348 LEU THR SER ALA LYS GLU LEU PRO TYR PHE GLU GLY ASP SEQRES 18 A 348 PHE TRP PRO ASN VAL LEU GLU GLU SER ILE LYS GLU LEU SEQRES 19 A 348 GLU GLN LYS THR SER LYS ASN LYS SER SER LEU SER ARG SEQRES 20 A 348 GLY ASN LYS LYS LYS PRO GLY MET PRO ASN VAL SER ASN SEQRES 21 A 348 ASP LEU SER GLN LYS LEU TYR ALA THR MET GLU LYS HIS SEQRES 22 A 348 LYS GLU VAL PHE PHE VAL ILE ARG LEU ILE ALA GLY PRO SEQRES 23 A 348 ALA ALA ASN SER LEU PRO PRO ILE VAL ASP PRO ASP PRO SEQRES 24 A 348 LEU ILE PRO CYS ASP LEU MET ASP GLY ARG ASP ALA PHE SEQRES 25 A 348 LEU THR LEU ALA ARG ASP ARG HIS LEU GLU PHE SER SER SEQRES 26 A 348 LEU ARG ARG ALA GLN TRP SER THR GLY CYS MET LEU VAL SEQRES 27 A 348 GLU LEU HIS THR GLN SER GLN ASP ARG PHE HET 6TF A1701 38 HET NA A1702 1 HETNAM 6TF N-[(4-FLUOROPHENYL)METHYL]-2-{(1R)-5- HETNAM 2 6TF [(METHYLCARBAMOYL)AMINO]-2',4'-DIOXO-2,3-DIHYDRO-3'H- HETNAM 3 6TF SPIRO[INDENE-1,5'-[1,3]OXAZOLIDIN]-3'-YL}-N-[(2S)-1,1, HETNAM 4 6TF 1-TRIFLUOROPROPAN-2-YL]ACETAMIDE HETNAM NA SODIUM ION HETSYN 6TF N-(4-FLUOROBENZYL)-2-((R)-5-(3-METHYLUREIDO)-2',4'- HETSYN 2 6TF DIOXO-2,3-DIHYDROSPIRO[INDENE-1,5'-OZAZOLIDINE]-3'- HETSYN 3 6TF YL)-N-((S)-1,1,1-TRIFLUOROPROPAN-2-YL)ACETAMIDE FORMUL 2 6TF C25 H24 F4 N4 O5 FORMUL 3 NA NA 1+ FORMUL 4 HOH *259(H2 O) HELIX 1 AA1 SER A 1289 LEU A 1293 5 5 HELIX 2 AA2 THR A 1296 ASN A 1314 1 19 HELIX 3 AA3 LYS A 1336 VAL A 1344 1 9 HELIX 4 AA4 PRO A 1406 CYS A 1408 5 3 HELIX 5 AA5 LEU A 1409 GLY A 1429 1 21 HELIX 6 AA6 LYS A 1459 GLU A 1477 1 19 HELIX 7 AA7 ILE A 1486 ASP A 1493 1 8 HELIX 8 AA8 SER A 1497 LEU A 1501 5 5 HELIX 9 AA9 ASP A 1507 GLN A 1522 1 16 HELIX 10 AB1 LEU A 1580 HIS A 1591 1 12 HELIX 11 AB2 ALA A 1602 ASN A 1607 5 6 HELIX 12 AB3 CYS A 1621 ASP A 1625 5 5 HELIX 13 AB4 ARG A 1627 ARG A 1637 1 11 HELIX 14 AB5 SER A 1643 GLN A 1661 1 19 SHEET 1 AA1 7 VAL A1321 GLU A1334 0 SHEET 2 AA1 7 SER A1352 ILE A1366 -1 O TYR A1355 N LYS A1331 SHEET 3 AA1 7 VAL A1369 TYR A1381 -1 O VAL A1369 N ILE A1366 SHEET 4 AA1 7 ARG A1392 SER A1400 -1 O ARG A1392 N TYR A1381 SHEET 5 AA1 7 THR A1432 TRP A1436 1 O THR A1432 N VAL A1393 SHEET 6 AA1 7 PHE A1595 ARG A1599 -1 O ILE A1598 N GLY A1433 SHEET 7 AA1 7 ASP A1482 ASP A1485 -1 N LYS A1484 O VAL A1597 CISPEP 1 PRO A 1387 PRO A 1388 0 8.04 CISPEP 2 ARG A 1405 PRO A 1406 0 -1.26 SITE 1 AC1 20 PHE A1374 LEU A1398 ASP A1399 SER A1400 SITE 2 AC1 20 TYR A1414 LEU A1418 PRO A1439 PRO A1440 SITE 3 AC1 20 HIS A1451 PRO A1452 GLN A1455 LYS A1456 SITE 4 AC1 20 ILE A1457 PRO A1458 ARG A1462 LEU A1463 SITE 5 AC1 20 TRP A1466 HOH A1811 HOH A1825 HOH A1902 SITE 1 AC2 4 TYR A1397 LEU A1398 TYR A1446 LYS A1526 CRYST1 45.192 102.944 168.438 90.00 90.00 90.00 C 2 2 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.022128 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009714 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005937 0.00000